Loading…

Whole genome sequencing for drug resistance determination in Mycobacterium tuberculosis

South Africa remains challenged with a high tuberculosis burden accompanied by an increase in drug resistant cases. We assessed the use of the Illumina MiSeq, a next-generation sequencing platform for whole genome sequencing, followed by bioinformatic analysis using a commercial software package to...

Full description

Saved in:
Bibliographic Details
Published in:African journal of laboratory medicine 2019, Vol.8 (1), p.1-5
Main Authors: Ismail, Nazir A., Said, Halima M., Ismail, Farzana, Ismail, Nabila, Omar, Shaheed V., Gwala, Thabisile L., Joseph, Lavania
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c571t-f10f3ac4c69c4c6279289bf0e6ef59884092d287f2dd578df2c27dde71839d543
cites cdi_FETCH-LOGICAL-c571t-f10f3ac4c69c4c6279289bf0e6ef59884092d287f2dd578df2c27dde71839d543
container_end_page 5
container_issue 1
container_start_page 1
container_title African journal of laboratory medicine
container_volume 8
creator Ismail, Nazir A.
Said, Halima M.
Ismail, Farzana
Ismail, Nabila
Omar, Shaheed V.
Gwala, Thabisile L.
Joseph, Lavania
description South Africa remains challenged with a high tuberculosis burden accompanied by an increase in drug resistant cases. We assessed the use of the Illumina MiSeq, a next-generation sequencing platform for whole genome sequencing, followed by bioinformatic analysis using a commercial software package to determine resistance to selected drugs used for Mycobacterium tuberculosis treatment in our setting. Whole genome sequencing shows potential as a diagnostic platform for the detection of drug resistance in Mycobacterium tuberculosis with the provision of information for several drugs simultaneously.
doi_str_mv 10.4102/ajlm.v8i1.801
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_923a544b5bf5434290ae0ab46ee11323</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sabinet_id>https://hdl.handle.net/10520/EJC-141aaa8ea5</sabinet_id><scielo_id>S2225_20102019000100002</scielo_id><doaj_id>oai_doaj_org_article_923a544b5bf5434290ae0ab46ee11323</doaj_id><sourcerecordid>2193080814</sourcerecordid><originalsourceid>FETCH-LOGICAL-c571t-f10f3ac4c69c4c6279289bf0e6ef59884092d287f2dd578df2c27dde71839d543</originalsourceid><addsrcrecordid>eNpVUk1v1DAQjRCIVqVH7pE4Z_E4X84FhFYFioo4AOrRmtiTxKvEXmynUv89DrsqqiV_aGbem5nnybK3wHYVMP4eD_OyexAGdoLBi-ySc14XnAF7-fRm_CK7DuHA0hI1CGheZxclE03ZQnuZ3d9PbqZ8JOsWygP9WckqY8d8cD7Xfh1zT8GEiFZRrimSX4zFaJzNjc2_PyrXo0pWsy55XHvyap1dArzJXg04B7o-31fZ7883v_Zfi7sfX273n-4KVbcQiwHYUKKqVNNtB287Lrp-YNTQUHdCVKzjmot24FrXrdADV7zVmloQZafrqrzKbk-82uFBHr1Z0D9Kh0b-Mzg_SvTRqJlkx0usq6qv-yEBK94xJIZ91RABlLxMXLsTV1CGZicPbvU2FS9_blrKTde0uyQkbGryBPhwAhzXfiGtyEaP87MqnnusmeToHmRTsbaENhG8OxN4l5QP8X9ODl36JSZg67E4RSnvQvA0PGUAJrc5kNscyG0OZJqDFP_x3Af2xlKUASnVIacYj0FOepYTWp0U2XzAas7kzbe9hAoQURDW5V-1iLot</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2193080814</pqid></control><display><type>article</type><title>Whole genome sequencing for drug resistance determination in Mycobacterium tuberculosis</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Ismail, Nazir A. ; Said, Halima M. ; Ismail, Farzana ; Ismail, Nabila ; Omar, Shaheed V. ; Gwala, Thabisile L. ; Joseph, Lavania</creator><creatorcontrib>Ismail, Nazir A. ; Said, Halima M. ; Ismail, Farzana ; Ismail, Nabila ; Omar, Shaheed V. ; Gwala, Thabisile L. ; Joseph, Lavania</creatorcontrib><description>South Africa remains challenged with a high tuberculosis burden accompanied by an increase in drug resistant cases. We assessed the use of the Illumina MiSeq, a next-generation sequencing platform for whole genome sequencing, followed by bioinformatic analysis using a commercial software package to determine resistance to selected drugs used for Mycobacterium tuberculosis treatment in our setting. Whole genome sequencing shows potential as a diagnostic platform for the detection of drug resistance in Mycobacterium tuberculosis with the provision of information for several drugs simultaneously.</description><identifier>ISSN: 2225-2002</identifier><identifier>ISSN: 2225-2010</identifier><identifier>EISSN: 2225-2010</identifier><identifier>DOI: 10.4102/ajlm.v8i1.801</identifier><identifier>PMID: 30863717</identifier><language>eng</language><publisher>Cape Town: AOSIS</publisher><subject>Brief Report ; Drug resistance ; Genomes ; Genotype &amp; phenotype ; Laboratories ; Medical Laboratory Technology ; Mutation ; Tuberculosis ; whole genome sequence</subject><ispartof>African journal of laboratory medicine, 2019, Vol.8 (1), p.1-5</ispartof><rights>2019. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2019. The Authors 2019</rights><rights>This work is licensed under a Creative Commons Attribution 4.0 International License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c571t-f10f3ac4c69c4c6279289bf0e6ef59884092d287f2dd578df2c27dde71839d543</citedby><cites>FETCH-LOGICAL-c571t-f10f3ac4c69c4c6279289bf0e6ef59884092d287f2dd578df2c27dde71839d543</cites><orcidid>0000-0003-4555-0244 ; 0000-0002-2287-1857 ; 0000-0002-7668-1178 ; 0000-0001-7696-3776 ; 0000-0003-0734-7149 ; 0000-0003-3070-9806 ; 0000-0001-6983-1636</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2193080814/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2193080814?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,4024,25753,27923,27924,27925,37012,44590,53791,53793,74998</link.rule.ids></links><search><creatorcontrib>Ismail, Nazir A.</creatorcontrib><creatorcontrib>Said, Halima M.</creatorcontrib><creatorcontrib>Ismail, Farzana</creatorcontrib><creatorcontrib>Ismail, Nabila</creatorcontrib><creatorcontrib>Omar, Shaheed V.</creatorcontrib><creatorcontrib>Gwala, Thabisile L.</creatorcontrib><creatorcontrib>Joseph, Lavania</creatorcontrib><title>Whole genome sequencing for drug resistance determination in Mycobacterium tuberculosis</title><title>African journal of laboratory medicine</title><addtitle>Afr. J. Lab. Med</addtitle><description>South Africa remains challenged with a high tuberculosis burden accompanied by an increase in drug resistant cases. We assessed the use of the Illumina MiSeq, a next-generation sequencing platform for whole genome sequencing, followed by bioinformatic analysis using a commercial software package to determine resistance to selected drugs used for Mycobacterium tuberculosis treatment in our setting. Whole genome sequencing shows potential as a diagnostic platform for the detection of drug resistance in Mycobacterium tuberculosis with the provision of information for several drugs simultaneously.</description><subject>Brief Report</subject><subject>Drug resistance</subject><subject>Genomes</subject><subject>Genotype &amp; phenotype</subject><subject>Laboratories</subject><subject>Medical Laboratory Technology</subject><subject>Mutation</subject><subject>Tuberculosis</subject><subject>whole genome sequence</subject><issn>2225-2002</issn><issn>2225-2010</issn><issn>2225-2010</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpVUk1v1DAQjRCIVqVH7pE4Z_E4X84FhFYFioo4AOrRmtiTxKvEXmynUv89DrsqqiV_aGbem5nnybK3wHYVMP4eD_OyexAGdoLBi-ySc14XnAF7-fRm_CK7DuHA0hI1CGheZxclE03ZQnuZ3d9PbqZ8JOsWygP9WckqY8d8cD7Xfh1zT8GEiFZRrimSX4zFaJzNjc2_PyrXo0pWsy55XHvyap1dArzJXg04B7o-31fZ7883v_Zfi7sfX273n-4KVbcQiwHYUKKqVNNtB287Lrp-YNTQUHdCVKzjmot24FrXrdADV7zVmloQZafrqrzKbk-82uFBHr1Z0D9Kh0b-Mzg_SvTRqJlkx0usq6qv-yEBK94xJIZ91RABlLxMXLsTV1CGZicPbvU2FS9_blrKTde0uyQkbGryBPhwAhzXfiGtyEaP87MqnnusmeToHmRTsbaENhG8OxN4l5QP8X9ODl36JSZg67E4RSnvQvA0PGUAJrc5kNscyG0OZJqDFP_x3Af2xlKUASnVIacYj0FOepYTWp0U2XzAas7kzbe9hAoQURDW5V-1iLot</recordid><startdate>2019</startdate><enddate>2019</enddate><creator>Ismail, Nazir A.</creator><creator>Said, Halima M.</creator><creator>Ismail, Farzana</creator><creator>Ismail, Nabila</creator><creator>Omar, Shaheed V.</creator><creator>Gwala, Thabisile L.</creator><creator>Joseph, Lavania</creator><general>AOSIS</general><general>AOSIS (Pty) Ltd</general><general>African Society for Laboratory Medicine (Ethiopia)</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><scope>GPN</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-4555-0244</orcidid><orcidid>https://orcid.org/0000-0002-2287-1857</orcidid><orcidid>https://orcid.org/0000-0002-7668-1178</orcidid><orcidid>https://orcid.org/0000-0001-7696-3776</orcidid><orcidid>https://orcid.org/0000-0003-0734-7149</orcidid><orcidid>https://orcid.org/0000-0003-3070-9806</orcidid><orcidid>https://orcid.org/0000-0001-6983-1636</orcidid></search><sort><creationdate>2019</creationdate><title>Whole genome sequencing for drug resistance determination in Mycobacterium tuberculosis</title><author>Ismail, Nazir A. ; Said, Halima M. ; Ismail, Farzana ; Ismail, Nabila ; Omar, Shaheed V. ; Gwala, Thabisile L. ; Joseph, Lavania</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c571t-f10f3ac4c69c4c6279289bf0e6ef59884092d287f2dd578df2c27dde71839d543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Brief Report</topic><topic>Drug resistance</topic><topic>Genomes</topic><topic>Genotype &amp; phenotype</topic><topic>Laboratories</topic><topic>Medical Laboratory Technology</topic><topic>Mutation</topic><topic>Tuberculosis</topic><topic>whole genome sequence</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ismail, Nazir A.</creatorcontrib><creatorcontrib>Said, Halima M.</creatorcontrib><creatorcontrib>Ismail, Farzana</creatorcontrib><creatorcontrib>Ismail, Nabila</creatorcontrib><creatorcontrib>Omar, Shaheed V.</creatorcontrib><creatorcontrib>Gwala, Thabisile L.</creatorcontrib><creatorcontrib>Joseph, Lavania</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health Medical collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Middle East &amp; Africa Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SciELO</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>African journal of laboratory medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ismail, Nazir A.</au><au>Said, Halima M.</au><au>Ismail, Farzana</au><au>Ismail, Nabila</au><au>Omar, Shaheed V.</au><au>Gwala, Thabisile L.</au><au>Joseph, Lavania</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Whole genome sequencing for drug resistance determination in Mycobacterium tuberculosis</atitle><jtitle>African journal of laboratory medicine</jtitle><addtitle>Afr. J. Lab. Med</addtitle><date>2019</date><risdate>2019</risdate><volume>8</volume><issue>1</issue><spage>1</spage><epage>5</epage><pages>1-5</pages><issn>2225-2002</issn><issn>2225-2010</issn><eissn>2225-2010</eissn><abstract>South Africa remains challenged with a high tuberculosis burden accompanied by an increase in drug resistant cases. We assessed the use of the Illumina MiSeq, a next-generation sequencing platform for whole genome sequencing, followed by bioinformatic analysis using a commercial software package to determine resistance to selected drugs used for Mycobacterium tuberculosis treatment in our setting. Whole genome sequencing shows potential as a diagnostic platform for the detection of drug resistance in Mycobacterium tuberculosis with the provision of information for several drugs simultaneously.</abstract><cop>Cape Town</cop><pub>AOSIS</pub><pmid>30863717</pmid><doi>10.4102/ajlm.v8i1.801</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0003-4555-0244</orcidid><orcidid>https://orcid.org/0000-0002-2287-1857</orcidid><orcidid>https://orcid.org/0000-0002-7668-1178</orcidid><orcidid>https://orcid.org/0000-0001-7696-3776</orcidid><orcidid>https://orcid.org/0000-0003-0734-7149</orcidid><orcidid>https://orcid.org/0000-0003-3070-9806</orcidid><orcidid>https://orcid.org/0000-0001-6983-1636</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2225-2002
ispartof African journal of laboratory medicine, 2019, Vol.8 (1), p.1-5
issn 2225-2002
2225-2010
2225-2010
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_923a544b5bf5434290ae0ab46ee11323
source Publicly Available Content Database; PubMed Central
subjects Brief Report
Drug resistance
Genomes
Genotype & phenotype
Laboratories
Medical Laboratory Technology
Mutation
Tuberculosis
whole genome sequence
title Whole genome sequencing for drug resistance determination in Mycobacterium tuberculosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T18%3A34%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Whole%20genome%20sequencing%20for%20drug%20resistance%20determination%20in%20Mycobacterium%20tuberculosis&rft.jtitle=African%20journal%20of%20laboratory%20medicine&rft.au=Ismail,%20Nazir%20A.&rft.date=2019&rft.volume=8&rft.issue=1&rft.spage=1&rft.epage=5&rft.pages=1-5&rft.issn=2225-2002&rft.eissn=2225-2010&rft_id=info:doi/10.4102/ajlm.v8i1.801&rft_dat=%3Cproquest_doaj_%3E2193080814%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c571t-f10f3ac4c69c4c6279289bf0e6ef59884092d287f2dd578df2c27dde71839d543%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2193080814&rft_id=info:pmid/30863717&rft_sabinet_id=https://hdl.handle.net/10520/EJC-141aaa8ea5&rft_scielo_id=S2225_20102019000100002&rfr_iscdi=true